Frontiers | Utility of Clinical–Radiomic Model to Identify Clinically Significant Prostate Cancer in Biparametric MRI PI-RADS V2.1 Category 3 Lesions
The Radiology Assistant : Prostate Cancer - PI-RADS v2
Gallium 68 PSMA-11 PET/CT Imaging in Patients with PI-RADS 3 | Journal of Nuclear Medicine
MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions? | Semantic Scholar
MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions? - Schoots - Translational Andrology and Urology
The basics of PI-RADS scoring and how AI can help
Prostate Imaging-Reporting and Data System (PI-RADS) | Radiology Reference Article | Radiopaedia.org
Avoiding Unnecessary Biopsy: MRI-based Risk Models versus a PI-RADS and PSA Density Strategy for Clinically Significant Prostate Cancer | Radiology
Risk‐adapted biopsy decision based on prostate magnetic resonance imaging and prostate‐specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation - Schoots - 2021 - BJU International - Wiley Online Library
Analysis of PI-RADS 4 cases_ Management recommendations for negatively biopsied patients
PI-RADS III (prostate cancer). a Axial T2-WI shows TZ heterogeneous... | Download Scientific Diagram
Single center analysis of an advisable control interval for follow-up of patients with PI-RADS category 3 in multiparametric MRI of the prostate | Scientific Reports
The basics of PI-RADS scoring and how AI can help
Life | Free Full-Text | Considering Predictive Factors in the Diagnosis of Clinically Significant Prostate Cancer in Patients with PI-RADS 3 Lesions
An integrated nomogram combining deep learning, Prostate Imaging–Reporting and Data System (PI-RADS) scoring, and clinical variables for identification of clinically significant prostate cancer on biparametric MRI: a retrospective multicentre study - The
Frontiers | New TRUS Techniques and Imaging Features of PI-RADS 4 or 5: Influence on Tumor Targeting
Prostate Imaging-Reporting and Data System (PI-RADS) | Radiology Reference Article | Radiopaedia.org
Decision tree for managing PI-RADS 3 lesions in African American men... | Download Scientific Diagram
PI-RADS Steering Committee: The PI-RADS Multiparametric MRI and MRI-directed Biopsy Pathway | Radiology
Followup of Men with PI-RADS™ 4 or 5 Abnormality on Prostate Magnetic Resonance Imaging and Nonmalignant Pathological Findings on Initial Targeted Prostate Biopsy | Journal of Urology
PI-RADS 3 lesions: Does the association of the lesion volume with the prostate-specific antigen density matter in the diagnosis of clinically significant prostate cancer? - ScienceDirect
JCM | Free Full-Text | New Biopsy Techniques and Imaging Features of Transrectal Ultrasound for Targeting PI-RADS 4 and 5 Lesions
Results from a PI-RADS-based MRI-directed diagnostic pathway for biopsy-naive patients in a non-university hospital | SpringerLink
PI-RADS 3 lesions: Does the association of the lesion volume with the prostate-specific antigen density matter in the diagnosis of clinically significant prostate cancer? - ScienceDirect
Early experience in avoiding biopsies for biopsy-naïve men with clinical suspicion of prostate cancer but non-suspicious biparametric magnetic resonance imaging results and prostate-specific antigen density < 0.15 ng/mL2: A 2-year follow-up study -
PI-RADS 3 Lesions: Does the Association of the Lesion Volume with the Prostate-Specific Antigen Density Matter in the Diagnosis of Clinically Significant Prostate Cancer? - Beyond the Abstract
Diagnostics | Free Full-Text | Does Adding Standard Systematic Biopsy to Targeted Prostate Biopsy in PI-RADS 3 to 5 Lesions Enhance the Detection of Clinically Significant Prostate Cancer? Should All Patients with
